Monsenso offers a digital tool as adjunct to medication, that enables pharma companies to collect real world data to uncover new scientific and commercial insights.
The solution consists of a mobile app for individuals and carers, as well as a web portal for clinicians or investigators. The patient app collects self-reported data on patient reported outcomes and sensor data from the app and wearables. The real-time data can helps clinicians to personalise the treatment and medication for better outcomes, while providing pharma with the real-world evidence base on efficacy and safety to support regulatory efforts and new value-based payment models.
The solution can be tailored to your specific needs and delivered as a white label product.
Click on this link to read more about Why Pharma can benefit from mHealth solutions.
Collect patient-reported outcome (ePRO) data from self-assessments, clinical questionnaires, as well as data from usage, voice analysis and sensors.
Improve medication adherence and treatment compliance through daily reminders coupled with maximum data security.
Engage patients throughout the patient journey and empower them to better manage their disease through better insights and tools.
Offer a digital health solution, that enables clinicians to remotely monitor patients in an easy and cost-efficient way.
Monsenso adheres to the highest security standards. It is classified as a class 1 CE device, and holds a TGA certification and a Cyber Essentials Certification.
Additionally, Monsenso A/S holds the ISO 13485 and the ISO 27001 certifications.
The solution is highly scalable and can be used by small clinics, large hospitals, trusts or healthcare regions as well as research purposes. Furthermore, it can also be configured to suit individual clinics, projects and disorders.